PharmaCyte BiotechPMCB 
$1.53-2.55%24h
-2.55%24h
Global rank31881
Market cap$29.82M
Change 7d-22.34%
YTD Performance-30.45%
SP500 benchmarkUnderperform
P/E-6.95
P/S0
Revenue$0
Earnings-$4.32M
Dividend yield-
Main Sector
Healthcare
PharmaCyte Biotech (PMCB) Cash on Hand
PMCB Cash on Hand in 2022: $68.04M
According to PharmaCyte Biotech latest financial reports the cash on hand of PMCB is $68.04M, an decrease of -20.33% to 2022. At the end of 2022 company had $85.40M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
PMCB Cash on Hand History from 2019 to 2023
-
Value:-
PMCB Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $68.04M | -20.33% |
| 2022 | $85.40M | 3778.14% |
| 2021 | $2.20M | 146.08% |
| 2020 | $894.86K | 73.67% |
| 2019 | $515.25K | - |
View the Top Cash on Hand Companies 
